Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carmel Biosensors was an Israeli medical device company that developed wearable biosensors intended for continuous monitoring of blood analytes, with an initial focus on glucose sensing for people with diabetes. Its lead product concepts included GlucAlarm, an early-warning patch for impending hypoglycemia, and GlucoGuard, a watch-like continuous glucose monitoring system. The company also described broader applications of its sensor technology for monitoring gases, hormones, drugs, and anesthetic agents. Carmel Biosensors appears to have ceased operations in 2002 after failing to secure additional financing, although its intellectual property remained of interest to investors and industry participants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carmel Biosensors.